Porton Advanced Solutions
company
About
Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
- 251 - 500
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $80M
- Industries
- Biotechnology,Genetics,Manufacturing,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$80M ¥400M
Porton Advanced Solutions has raised a total of
$80M ¥400M
in funding over 2 rounds. Their latest funding was raised on
Aug 21, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 21, 2022 | Series B | $80M | 4 | — | — | Detail |
| Apr 16, 2021 | Series A | ¥400M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
5
Porton Advanced Solutions is funded by 5 investors.
China Merchants Securities
and Ruilin Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
China Merchants Securities
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
